Scientists have taken a giant leap forward with the development of tiny microneedles designed to detect subtle but critical ...
Organoids are miniature tissue or organ models formed by stem cells (including pluripotent stem cells, tissue-specific adult ...
Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat ...
A hantavirus vaccine is currently in preclinical development, but a publicly available shot is likely years away. Other ...
Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to ...
Actio launches dedicated patient resource to support families seeking information about the KYRON clinical trial at ...
The US Food and Drug Administration (FDA) has released a final guidance document with immediate effect advising sponsors on ...
City Therapeutics, Inc., a biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, presented ...
Stroke drug developer Argenica Therapeutics plans a second trial to test its novel candidate, in a sector that has few ...
FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
Peptide therapeutics require tailored ADME strategies to address stability, supporting more effective and reliable drug ...
Comprehending the spate of recent rejections in the cell and gene therapy space may require looking no further than ...